GET CONTRAVE NOW
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 22 Apr 2024)
What this means for you
Registered since 16 Oct 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87301815
- Registration number
- 5586961
- Mark type
- Stylized text
- Filed
- 13 Jan 2017
- Published for opposition
- 20 Jun 2017
- Registered
- 16 Oct 2018
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 044 — Medical, beauty and agricultural services: Online pharmaceutical advice, namely, providing online consultation and information for the ordering of pharmaceuticals; Providing information in the field of weight management and the treatment of obesity
Owner
- NALPROPION PHARMACEUTICALS LLC, Brentwood, TN, US
- NALPROPION PHARMACEUTICALS, INC., MORRISTOWN, NJ, US
- NALPROPION PHARMACEUTICALS, INC., MORRISTOWN, NJ, US
- Orexigen Therapeutics, Inc., La Jolla, CA, US
- Orexigen Therapeutics, Inc., La Jolla, CA, US
Prior registrations
Prosecution history
- 22 Apr 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 22 Apr 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 22 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Oct 2023 — TEAS SECTION 8 & 15 RECEIVED
- 16 Oct 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Jul 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Jul 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Oct 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 16 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 12 Sept 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Sept 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE